Celiac Disease: Caught Between a Rock and a Hard Place

Slides:



Advertisements
Similar presentations
Principles of Immunology Major Histocompatibility Complex 2/28/06 “Change is not merely necessary for life. It is life.” A Toffler.
Advertisements

Antigen Processing and Presentation
Chapter 7. 주조직적합성 복합체 1. 주조직적합성 복합체 (MHC)의 발견 2. MHC 분자의 구조
Celiac Disease: An Immunological Jigsaw
Current concepts of celiac disease pathogenesis
The Major Histocompatibility Complex (MHC)
Spondyloarthritis: update on pathogenesis and management
Chapter 8 Major Histocompatibility Complex
Figure 1 CTLA-4 and PD-1–PD-L1 immune checkpoints
Louise E. Glover, Sean P. Colgan  Gastroenterology 
Volume 27, Issue 1, Pages (July 2007)
Chapter 8 Major Histocompatibility Complex Dr. Capers
Laurent L'homme, PhD, David Dombrowicz, PhD 
Overview and pathogenesis of celiac disease
Enzyme-modified wheat gliadin activates T cells in celiac disease
Volume 149, Issue 6, Pages e2 (November 2015)
Celiac Disease Genetics: Current Concepts and Practical Applications
Microbial Influences in Inflammatory Bowel Diseases
Volume 9, Issue 2, Pages (February 2002)
Tumor necrosis factor: Biology and therapeutic inhibitors
Turning Swords Into Plowshares: Transglutaminase to Detoxify Gluten
Colorectal cancer vaccines: Principles, results, and perspectives
Crystal Structure of M. tuberculosis ABC Phosphate Transport Receptor
The Gastrointestinal Tract and AIDS Pathogenesis
T-Cell Response to Gluten in Patients With HLA-DQ2
Stefan H.E. Kaufmann, Shreemanta K. Parida  Cell Host & Microbe 
Benoit Chassaing, Arlette Darfeuille–Michaud  Gastroenterology 
A Molecular Warhead and Its Target
Spreading and focusing of gluten epitopes in celiac disease
Daniel Abate-Daga, Marco L Davila  Molecular Therapy - Oncolytics 
Spondyloarthritis: update on pathogenesis and management
Volume 27, Issue 1, Pages (July 2007)
Enzyme-modified wheat gliadin activates T cells in celiac disease
Unraveling the Pros and Cons of Interferon-γ Gene Regulation
The Major Histocompatibility Complex (MHC)
Current concepts of celiac disease pathogenesis
Warren Strober, Ivan J. Fuss  Gastroenterology 
A New Link in the Chain from Amino Acids to mTORC1 Activation
Biology and Treatment of Eosinophilic Esophagitis
The Genetics of Inflammatory Bowel Disease
Celiac Disease: From Pathogenesis to Novel Therapies
Darren Thompson, Mark B Pepys, Steve P Wood  Structure 
Volume 146, Issue 7, Pages (June 2014)
Percy A. Knolle, Robert Thimme  Gastroenterology 
Dichotomous Role of Interferon-γ in Allogeneic Bone Marrow Transplant
Volume 24, Issue 10, Pages (October 2016)
Vaccinating Against Helicobacter pylori: Dissecting the Mechanism
Inflammasomes in Intestinal Inflammation and Cancer
Pavel Strnad, M. Bishr Omary  Gastroenterology 
The Relationship of MHC-Peptide Binding and T Cell Activation Probed Using Chemically Defined MHC Class II Oligomers  Jennifer R Cochran, Thomas O Cameron,
PARP Goes Transcription
Interleukin-18 in Intestinal Inflammation: Friend and Foe?
Claude Daniel, Stephen Horvath, Paul M Allen  Immunity 
Volume 15, Issue 6, Pages (December 2001)
Molecular Features of Penicillin Allergy
Volume 122, Issue 7, Pages (June 2002)
Janine Bilsborough, Joanne L. Viney  Gastroenterology 
Mesenchymal Stromal Cells: Sensors and Switchers of Inflammation
Volume 133, Issue 3, Pages (September 2007)
Volume 125, Issue 4, Pages (October 2003)
Gene targeting: Applications in transplantation research
Volume 119, Issue 4, Pages (October 2000)
Even Neurons Are Excited by Th17 Cells
IgA nephropathy: markers of progression and clues to pathogenesis
Keeping STATs on Memory CD8+ T Cells
Volume 7, Issue 1, Pages 1-11 (July 1997)
Tumor necrosis factor: Biology and therapeutic inhibitors
Clara Abraham, Ruslan Medzhitov  Gastroenterology 
The Relationship of MHC-Peptide Binding and T Cell Activation Probed Using Chemically Defined MHC Class II Oligomers  Jennifer R Cochran, Thomas O Cameron,
Toll-like receptors, adapter proteins, and signaling molecules.
Presentation transcript:

Celiac Disease: Caught Between a Rock and a Hard Place Frits Koning  Gastroenterology  Volume 129, Issue 4, Pages 1294-1301 (October 2005) DOI: 10.1053/j.gastro.2005.07.030 Copyright © 2005 American Gastroenterological Association Terms and Conditions

Figure 1 Interaction between the T-cell receptor on T cells and a gluten-derived peptide bound to HLA-DQ2 on APCs leads to T-cell activation. CD-predisposing HLA-DQ2 dimers can be formed in a number of ways. HLA-DQ expression is linked to HLA-DR expression as indicated. The DQα*0501 and DQα*0505 chains are very similar and so are the DQβ*0201 and DQβ*0202 chains. The other HLA-DQ chains shown are distinct. HLA-DQ2 dimers with identical peptide-binding properties thus can be formed by all red–green combinations. Accordingly, CD is observed most frequently in DR3+- and DR5/7+-positive individuals. Gastroenterology 2005 129, 1294-1301DOI: (10.1053/j.gastro.2005.07.030) Copyright © 2005 American Gastroenterological Association Terms and Conditions

Figure 2 Binding of peptides to HLA-DQ2. HLA-DQ2 has a preference for particular amino acids (anchor residues) at 5 positions in bound peptides: at p1, p4, p6, p7, and p9. In a peptide that is present abundantly in HLA-DQ2 molecules (natural ligand), all 5 anchor residues are present. The HLA-DQ2–gliadin crystal structure indicates that only 4 anchors are used and that not all are optimal.14 Likewise, in the glutenin peptide only 4 anchors are used.61 The binding of peptide is facilitated by additional hydrogen bonds between HLA-DQ2 and the peptide backbone (not shown). Gastroenterology 2005 129, 1294-1301DOI: (10.1053/j.gastro.2005.07.030) Copyright © 2005 American Gastroenterological Association Terms and Conditions

Figure 3 tTG activity either results in cross-linking of proteins by formation of a covalent bond between a glutamine in 1 protein to a lysine in another or to the conversion of glutamine into glutamic acid. Gastroenterology 2005 129, 1294-1301DOI: (10.1053/j.gastro.2005.07.030) Copyright © 2005 American Gastroenterological Association Terms and Conditions

Figure 4 (A) Formation of HLA-DQ molecules in HLA-DQ2 homozygous and HLA-DQ2/DQx heterozygous individuals. The HLA locus is encoded on chromosome 6. HLA-DQ2 homozygous individuals encode identical DQα and -α chains on both of their chromosome 6 whereas HLA-DQ2/DQx heterozygous individuals will encode HLA-DQ2 on 1 and another HLA-DQα and -β chains on the other chromosome 6. Consequently, HLA-DQ2 homozygous individuals can form only 1 HLA-DQ dimer whereas HLA-DQ2/DQx heterozygous individuals can form 4. (B) Formation of HLA-DQ2 gluten peptide as a function of the number of available HLA-DQ2 molecules and gluten peptides. HLA-DQ2 homozygotes will be able to form larger numbers of immunogenic complexes and break through the threshold although heterozygotes still are the safe zone. Adapted from Vader et al.38 Gastroenterology 2005 129, 1294-1301DOI: (10.1053/j.gastro.2005.07.030) Copyright © 2005 American Gastroenterological Association Terms and Conditions

Figure 5 Caught between a rock and a hard place. In the lamina propria, T cells respond to multiple gluten peptides bound to HLA-DQ2 and/or HLA-DQ8 on APCs, which results in a release of inflammatory cytokines, including interferon-γ. Interferon-γ–induced up-regulation of HLA-DQ expression will enhance gluten–peptide binding. Cellular damage caused by the inflammation will release intracellular tTG. This will result in additional gluten modification, contributing to enhanced T-cell reactivity toward gluten. APC activation also may lead to an increase in IL-15 production. Simultaneously and independent of the gluten-specific T-cell response, gluten can induce IL-15 production though an unidentified mechanism (unidentified receptor on enterocytes?). The increase in IL-15 levels leads to NKG2D and MICA up-regulation on IELs and enterocytes, respectively, and results in enterocyte destruction. Gastroenterology 2005 129, 1294-1301DOI: (10.1053/j.gastro.2005.07.030) Copyright © 2005 American Gastroenterological Association Terms and Conditions